📈 Markets & Finance
Live
Medexus Pharmaceuticals Inc. Q1 Sales Increase
(RTTNews) - Medexus Pharmaceuticals Inc. (MEDXF.OB) reported earnings for first quarter of $0.544 million The company's bottom line totaled $0.544 million, or $0.02 per share. This compares with $0.…
Nasdaq News — 10 August 2026
Text:
16
0
0
(RTTNews) - Medexus Pharmaceuticals Inc. (MEDXF.OB) reported earnings for first quarter of $0.544 million
The company's bottom line totaled $0.544 million, or $0.02 per share. This compares with $0.516 million, or $0.02 per share, last year.
The company's revenue for the period rose 16.1% to $28.59 million from $24.62 million last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
XDC AI and the Rise of Agentic Finance: When AI Agents Learn to Pay
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
I spent years in finance. Then I realized rural Japan's rice terraces were an overlooked asset.
📈 Markets & Finance
Couple holds monthly money dates, avoiding financial arguments for ten years
📈 Markets & Finance
Exxon and Chevron profits surge on rising oil prices due to Iran war
📈 Markets & Finance
HubSpot cuts customer-growth forecast to 5,000 per quarter
